Apton Biosystems
Geoff Smith, Ph.D. is a leader in genomics technologies and applications. Most recently he served as CEO of Cambridge Epigenetix. Geoff was Vice President at Illumina, where he served for over 10 years, having joined the company via the acquisition of Solexa. Geoff led the invention of many aspects of the core sequencing technology and workflow and platforms such as the MiSeq and HiSeq. Prior to Solexa, Geoff was head of research at Adprotech, a company he also joined from start-up. Geoff has a first degree and Ph.D. from Cambridge University and held postdoctoral research positions with HHMI at UT Southwestern, USA, and MRC Cambridge, UK.
This person is not in the org chart
This person is not in any offices
Apton Biosystems
Apton Biosystems is a Pleasanton, California-based developer of Super-Res(TM) sequencing and single-molecule detection systems for large-scale clinical applications such as early cancer detection and population sequencing.